|
1
|
Khoo CP, Pozzilli P and Alison MR:
Endothelial progenitor cells and their potential therapeutic
applications. Regen Med. 3:863–876. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fadini GP, Losordo D and Dimmeler S:
Critical reevaluation of endothelial progenitor cell phenotypes for
therapeutic and diagnostic use. Circ Res. 110:624–637. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang C, Zhang ZH, Li ZJ, Yang RC, Qian GQ
and Han ZC: Enhancement of neovascularization with cord blood
CD133+ cell-derived endothelial progenitor cell
transplantation. Thromb Haemost. 91:1202–1212. 2004.PubMed/NCBI
|
|
4
|
Ott I, Keller U, Knoedler M, Götze KS,
Doss K, Fischer P, Urlbauer K, Debus G, von Bubnoff N, Rudelius M,
et al: Endothelial-like cells expanded from CD34 blood cells
improve left ventricular function after experimental myocardial
infarction. FASEB J. 19:992–994. 2005.PubMed/NCBI
|
|
5
|
Toda N: Age-related changes in endothelial
function and blood flow regulation. Pharmacol Ther. 133:159–176.
2012. View Article : Google Scholar
|
|
6
|
Loomans CJ, de Koning EJ, Staal FJ,
Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B,
Rabelink TJ and van Zonneveld AJ: Endothelial progenitor cell
dysfunction: a novel concept in the pathogenesis of vascular
complications of type 1 diabetes. Diabetes. 53:195–199. 2004.
View Article : Google Scholar
|
|
7
|
Shimada K, Mokuno H, Matsunaga E, Miyazaki
T, Sumiyoshi K, Miyauchi K and Daida H: Circulating oxidized
low-density lipoprotein is an independent predictor for cardiac
event in patients with coronary artery disease. Atherosclerosis.
174:343–347. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shimada K, Mokuno H, Matsunaga E, Miyazaki
T, Sumiyoshi K, Kume A, Miyauchi K and Daida H: Predictive value of
circulating oxidized LDL for cardiac events in type 2 diabetic
patients with coronary artery disease. Diabetes Care. 27:843–844.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ma FX, Zhou B, Chen Z, Ren Q, Lu SH,
Sawamura T and Han ZC: Oxidized low density lipoprotein impairs
endothelial progenitor cells by regulation of endothelial nitric
oxide synthase. J Lipid Res. 47:1227–1237. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rosso A, Balsamo A, Gambino R, Dentelli P,
Falcioni R, Cassader M, Pegoraro L, Pagano G and Brizzi MF: p53
mediates the accelerated onset of senescence of endothelial
progenitor cells in diabetes. J Biol Chem. 281:4339–4347. 2006.
View Article : Google Scholar
|
|
11
|
Imanishi T, Hano T, Matsuo Y and Nishio I:
Oxidized low-density lipoprotein inhibits vascular endothelial
growth factor-induced endothelial progenitor cell differentiation.
Clin Exp Pharmacol Physiol. 30:665–670. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu L, Liu ZZ, Chen H, Zhang GJ, Kong YH
and Kang XX: Oxidized low-density lipoprotein and
β-glycerophosphate synergistically induce endothelial progenitor
cell ossification. Acta Pharmacol Sin. 32:1491–1497. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Imanishi T, Hano T, Sawamura T and Nishio
I: Oxidized low-density lipoprotein induces endothelial progenitor
cell senescence, leading to cellular dysfunction. Clin Exp
Pharmacol Physiol. 31:407–413. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hill JM, Zalos G, Halcox JP, Schenke WH,
Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial
progenitor cells, vascular function, and cardiovascular risk. N
Engl J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lai P and Liu Y: Angelica sinensis
polysaccharides inhibit endothelial progenitor cell senescence
through the reduction of oxidative stress and activation of the
Akt/hTERT pathway. Pharm Biol. 53:1842–1849. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dahl TB, Holm S, Aukrust P and Halvorsen
B: Visfatin/NAMPT: a multifaceted molecule with diverse roles in
physiology and pathophysiology. Annu Rev Nutr. 32:229–243. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
van der Veer E, Ho C, O'Neil C, Barbosa N,
Scott R, Cregan SP and Pickering JG: Extension of human cell
lifespan by nicotinamide phosphoribosyltransferase. J Biol Chem.
282:10841–10845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tie G, Yan J, Yang Y, Park BD, Messina JA,
Raffai RL, Nowicki PT and Messina LM: Oxidized low-density
lipoprotein induces apoptosis in endothelial progenitor cells by
inactivating the phosphoinositide 3-kinase/Akt pathway. J Vasc Res.
47:519–530. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Breitschopf K, Zeiher AM and Dimmeler S:
Pro-atherogenic factors induce telomerase inactivation in
endothelial cells through an Akt-dependent mechanism. FEBS Lett.
493:21–25. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kume S, Kitada M, Kanasaki K, Maegawa H
and Koya D: Anti-aging molecule, Sirt1: a novel therapeutic target
for diabetic nephropathy. Arch Pharm Res. 36:230–236. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Braidy N, Poljak A, Grant R, Jayasena T,
Mansour H, Chan-Ling T, Smythe G, Sachdev P and Guillemin GJ:
Differential expression of sirtuins in the aging rat brain. Front
Cell Neurosci. 9:1672015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kume S, Haneda M, Kanasaki K, Sugimoto T,
Araki S, Isono M, Isshiki K, Uzu T, Kashiwagi A and Koya D: Silent
information regulator 2 (SIRT1) attenuates oxidative stress-induced
mesangial cell apoptosis via p53 deacetylation. Free Radic Biol
Med. 40:2175–2182. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bakogiannis C, Tousoulis D, Androulakis E,
Briasoulis A, Papageorgiou N, Vogiatzi G, Kampoli AM, Charakida M,
Siasos G, Latsios G, et al: Circulating endothelial progenitor
cells as biomarkers for prediction of cardiovascular outcomes. Curr
Med Chem. 19:2597–2604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reynolds JA, Robertson AC, Bruce IN and
Alexander MY: Improving cardiovascular outcomes in rheumatic
diseases: therapeutic potential of circulating endothelial
progenitor cells. Pharmacol Ther. 142:231–243. 2014. View Article : Google Scholar
|
|
25
|
Werner N, Kosiol S, Schiegl T, Ahlers P,
Walenta K, Link A, Böhm M and Nickenig G: Circulating endothelial
progenitor cells and cardiovascular outcomes. N Engl J Med.
353:999–1007. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi T, Kalka C, Masuda H, Chen D,
Silver M, Kearney M, Magner M, Isner JM and Asahara T: Ischemia-
and cytokine-induced mobilization of bone marrow-derived
endothelial progenitor cells for neovascularization. Nat Med.
5:434–438. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aicher A, Rentsch M, Sasaki K, Ellwart JW,
Fändrich F, Siebert R, Cooke JP, Dimmeler S and Heeschen C: Nonbone
marrow-derived circulating progenitor cells contribute to postnatal
neovascularization following tissue ischemia. Circ Res.
100:581–589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ji KT, Qian L, Nan JL, Xue YJ, Zhang SQ,
Wang GQ, Yin RP, Zhu YJ, Wang LP, Ma J, et al: Ox-LDL induces
dysfunction of endothelial progenitor cells via activation of
NF-κB. BioMed Res Int. 2015:1752912015. View Article : Google Scholar
|
|
29
|
Cheng J, Cui R, Chen CH and Du J: Oxidized
low-density lipoprotein stimulates p53-dependent activation of
proapoptotic Bax leading to apoptosis of differentiated endothelial
progenitor cells. Endocrinology. 148:2085–2094. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu Y, Wang Q, Cheng L, Wang J and Lu G:
Effect of oxidized low-density lipoprotein on survival and function
of endothelial progenitor cell mediated by p38 signal pathway. J
Cardiovasc Pharmacol. 53:151–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Revollo JR, Körner A, Mills KF, Satoh A,
Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR,
et al: Nampt/PBEF/visfatin regulates insulin secretion in beta
cells as a systemic NAD biosynthetic enzyme. Cell Metab. 6:363–375.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Poulose N and Raju R: Sirtuin regulation
in aging and injury. Biochim Biophys Acta. 1852:2442–2455. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Balestrieri ML, Rienzo M, Felice F,
Rossiello R, Grimaldi V, Milone L, Casamassimi A, Servillo L,
Farzati B, Giovane A and Napoli C: High glucose downregulates
endothelial progenitor cell number via SIRT1. Biochim Biophys Acta.
1784:936–945. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yuan Q, Hu CP, Gong ZC, Bai YP, Liu SY, Li
YJ and Jiang JL: Accelerated onset of senescence of endothelial
progenitor cells in patients with type 2 diabetes mellitus: role of
dimethylarginine dimethylaminohydrolase 2 and asymmetric
dimethylarginine. Biochem Biophys Res Commun. 458:869–876. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ackah E, Yu J, Zoellner S, Iwakiri Y,
Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, et
al: Akt1/protein kinase Balpha is critical for ischemic and
VEGF-mediated angiogenesis. J Clin Invest. 115:2119–2127. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lefevre J, Michaud SE, Haddad P, Dussault
S, Ménard C, Groleau J, Turgeon J and Rivard A: Moderate
consumption of red wine (cabernet sauvignon) improves
ischemia-induced neovascularization in ApoE-deficient mice: effect
on endothelial progenitor cells and nitric oxide. FASEB J.
21:3845–3852. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chou WW, Chen KC, Wang YS, Wang JY, Liang
CL and Juo SH: The role of SIRT1/AKT/ERK pathway in ultraviolet B
induced damage on human retinal pigment epithelial cells. Toxicol
In Vitro. 27:1728–1736. 2013. View Article : Google Scholar : PubMed/NCBI
|
